Asthma in elite athletes: pathogenesis, diagnosis, differential diagnoses, and treatment
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Asthma in elite athletes: pathogenesis, diagnosis, differential diagnoses, and treatment. / Pedersen, Lars; Elers, Jimmi; Backer, Vibeke.
In: Physician and Sportsmedicine, Vol. 39, No. 3, 01.10.2011, p. 163-71.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Asthma in elite athletes: pathogenesis, diagnosis, differential diagnoses, and treatment
AU - Pedersen, Lars
AU - Elers, Jimmi
AU - Backer, Vibeke
PY - 2011/10/1
Y1 - 2011/10/1
N2 - Elite athletes have a high prevalence of asthma and exercise-induced bronchoconstriction. Although respiratory symptoms can be suggestive of asthma, the diagnosis of asthma in elite athletes cannot be based solely on the presence or absence of symptoms; diagnosis should be based on objective measurements, such as the eucapnic voluntary hyperpnea test or exercise test. When considering that not all respiratory symptoms are due to asthma, other diagnoses should be considered. Certain regulations apply to elite athletes who require asthma medication for asthma. Knowledge of these regulations is essential when treating elite athletes. This article is aimed at physicians who diagnose and treat athletes with respiratory symptoms. It focuses on the pathogenesis of asthma and exercise-induced bronchoconstriction in elite athletes and how the diagnosis can be made. Furthermore, treatment of elite athletes with asthma, anti-doping regulations, and differential diagnoses such as exercise-induced laryngomalacia are discussed.
AB - Elite athletes have a high prevalence of asthma and exercise-induced bronchoconstriction. Although respiratory symptoms can be suggestive of asthma, the diagnosis of asthma in elite athletes cannot be based solely on the presence or absence of symptoms; diagnosis should be based on objective measurements, such as the eucapnic voluntary hyperpnea test or exercise test. When considering that not all respiratory symptoms are due to asthma, other diagnoses should be considered. Certain regulations apply to elite athletes who require asthma medication for asthma. Knowledge of these regulations is essential when treating elite athletes. This article is aimed at physicians who diagnose and treat athletes with respiratory symptoms. It focuses on the pathogenesis of asthma and exercise-induced bronchoconstriction in elite athletes and how the diagnosis can be made. Furthermore, treatment of elite athletes with asthma, anti-doping regulations, and differential diagnoses such as exercise-induced laryngomalacia are discussed.
U2 - http://dx.doi.org/10.3810/psm.2011.09.1932
DO - http://dx.doi.org/10.3810/psm.2011.09.1932
M3 - Journal article
VL - 39
SP - 163
EP - 171
JO - Physician and Sportsmedicine
JF - Physician and Sportsmedicine
SN - 0091-3847
IS - 3
ER -
ID: 40141236